Physical fitness in children with type 1 diabetes measured with six-minute walk test

Vladimir Jegdic1, Zeljko Roncevic, Veselin Skrabic

  • 1Department of Pediatrics, University Hospital, 88000 Mostar, Bosnia and Herzegovina.

Insights

Children with type 1 diabetes (T1D) demonstrate reduced physical fitness compared to healthy peers. Elevated HbA1c levels did not correlate with decreased fitness in these children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Sports Medicine

Background:

  • Type 1 diabetes (T1D) is a chronic condition affecting children.
  • Physical fitness is crucial for overall health and well-being in pediatric populations.
  • Understanding the impact of T1D on physical fitness is essential for comprehensive management.

Purpose of the Study:

  • To compare the physical fitness of children with T1D to that of healthy controls.
  • To investigate the association between glycated hemoglobin A1c (HbA1c) levels and physical fitness in children with T1D.

Main Methods:

  • A case-control study involving 100 children with T1D (aged 7-17.9 years) and matched healthy controls.
  • Physical fitness assessed using the 6-minute walk test (6MWT), measuring distance, heart rate, and oxygen saturation.

Main Results:

  • Children with T1D walked significantly shorter distances (601.3m) than controls (672.1m) during the 6MWT (P < 0.001).
  • Lower pulse oxygen saturation was observed in children with T1D at pretest (P < 0.001).
  • HbA1c levels above 8% did not show a significant difference in physical fitness compared to those below 8% within the T1D group.

Conclusions:

  • Children diagnosed with T1D exhibit diminished physical fitness compared to their healthy counterparts.
  • Glycemic control, as indicated by HbA1c levels, did not appear to influence the physical fitness outcomes in this pediatric cohort.

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...